NCT05645003 Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
| NCT ID | NCT05645003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-11-15 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-11-15 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury. In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain. In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.
Eligibility Criteria
Inclusion Criteria: Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury and * Having spinal cord injury with neurophatic pain at least six months ago, * Able to follow two-stage verbal commands, * Agreeing to participate in the study voluntarily and regularly, * Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study. Exclusion Criteria: Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension, * Epilepsy, * History of antiepileptic drug use, * Intracranial metal object, * Presence of in-ear implant, * Cognitive dysfunction, * Lower extremity peripheral nerve injury, * With malignancy and active infection, * Infection on the skin in the application area, * Having an open wound, * Having inflammatory disease, * Orthopedic injuries that can limit maximum effort contractions, * Having a brain lesion or a history of drug use that will affect the seizure threshold, * Patients with increased intracranial pressure or uncontrolled migraine will not be included.
Contact & Investigator
Nuran EYVAZ, MD
PRINCIPAL INVESTIGATOR
Afyonkarahisar Health Sciences University
Frequently Asked Questions
Who can join the NCT05645003 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 70 Years, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05645003 currently recruiting?
Yes, NCT05645003 is actively recruiting participants. Contact the research team at n_eyvaz@hotmail.com for enrollment information.
Where is the NCT05645003 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT05645003 clinical trial?
NCT05645003 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Nuran EYVAZ, MD at Afyonkarahisar Health Sciences University. The trial plans to enroll 60 participants.